GRIDD receives funding to develop drugs to treat schizophrenia
Paving the way for personalised medicine, Griffith University researchers will use stem cells from nasal biopsies of people with schizophrenia...
Paving the way for personalised medicine, Griffith University researchers will use stem cells from nasal biopsies of people with schizophrenia...
The Griffith Institute for Drug Discovery has become the new home for a uniquely curated library of 329,000 chemical compounds used to advance drug research in Australia.
Professor Katherine Andrews, Director of the Griffith Institute for Drug Discovery (GRIDD), has been recognised as a Fellow of the Australian Society for Parasitology for her work on malaria drug discovery.
Scientists at Griffith University are moving towards animal trials in testing a vaccine candidate for COVID-19
Leading drug discoveryinstitute announced newmember of the Association of Australian Medical Research Institutes.
A Griffith University researcher says we urgently need to safeguard current antibiotics and discover new ones to avoid what has...
Professor Jennifer Martin has been honoured by HRH Prince Andrew as a Bragg Member with the Royal Institute of Australia....
Griffith Institute for Drug Discovery’s (GRIDD) Director Professor Jennifer Martin is the second woman to receive the prestigiousWunderly Oration Medal...
Hope is on the horizon for needle-phobic patients as Griffith University researchers have created a new influenza vaccine composition designed to be administered via the nose.
A Phase I human clinical trial is set to commence to test the efficacy and safety of the transplantation of olfactory cell nerve bridges to treat chronic spinal cord injury.